L3Harris Technologies, Inc.
Close on Nov 2, 2026Market cap $51.95BP/E 26.0Yield 1.72%
L3Harris Technologies Company-Funded R&D as % of Consolidated Revenue by Quarter
Company-Funded R&D as % of Consolidated Revenue (%)
L3Harris Technologies Company-Funded R&D as % of Consolidated Revenue: 2.4% in Q3 2026, unchanged from a year earlier.
Where the Q3 2026 figure comes from
Source: LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗
Reported in Form 8-K Q3 2026 Financial Supplement.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Company-Funded R&D as % of Consolidated Revenue (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 2.4% | 0.0 pts | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
| Q2 2026 | Jun 30, 2026 | 2.7% | +0.3 pts | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
| Q1 2026 | Mar 31, 2026 | 2.5% | +0.3 pts | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 2.7% | – | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
| Q3 2025 | Sep 30, 2025 | 2.4% | – | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 2.4% | – | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
| Q1 2025 | Mar 31, 2025 | 2.2% | – | LHX Q3 2026 Form 8-K Financial Supplement & Recast Appendix (filed 2026-10-29) ↗ |
Cite this data
StockData. (2026). L3Harris Technologies Company-Funded R&D as % of Consolidated Revenue (%), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from L3Harris Technologies SEC filings and investor materials. https://stockdatahq.com/stocks/lhx/kpis/tot-rd-pct
See every metric in the L3Harris Technologies KPI table. Data updated Nov 3, 2026.